LA JOLLA PHARMACEUTICAL CO Insider Trading for October 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LA JOLLA PHARMACEUTICAL CO for October 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 24 2019 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Option Exercise | A | 8.43 | 18,000 | 151,740 | 18,000 | |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 8.38 | 224 | 1,877 | 224 | |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.12 | 224 | 1,595 | 2,950 | 2.7 K to 3 K (+8.22 %) |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 8.38 | 81 | 679 | 81 | |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 7.12 | 81 | 577 | 6,498 | 6.4 K to 6.5 K (+1.26 %) |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 8.38 | 224 | 1,877 | 224 | |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 7.12 | 224 | 1,595 | 4,223 | 4 K to 4.2 K (+5.60 %) |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 8.38 | 112 | 939 | 112 | |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.12 | 112 | 797 | 79,336 | 79.2 K to 79.3 K (+0.14 %) |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 8.80 | 107 | 942 | 107 | |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.48 | 107 | 800 | 79,224 | 79.1 K to 79.2 K (+0.14 %) |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 8.80 | 213 | 1,874 | 213 | |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 7.48 | 213 | 1,593 | 3,999 | 3.8 K to 4 K (+5.63 %) |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 8.80 | 76 | 669 | 76 | |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 7.48 | 76 | 568 | 6,417 | 6.3 K to 6.4 K (+1.20 %) |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 8.80 | 213 | 1,874 | 213 | |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.48 | 213 | 1,593 | 2,726 | 2.5 K to 2.7 K (+8.48 %) |